Tag:

adult vaccines

Latest Headlines

Latest Headlines

Takeda snaps up LigoCyte for $60M

Takeda acquired LigoCyte Pharmaceuticals for $60 million, with potential future payouts that were undisclosed.

20 Top-selling Vaccines-- H1 2012

As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales.

The 20 top-selling vaccines in H1 2012

As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales. Take a look at the full list >>

ASU's Biodesign Institute enhances salmonella vaccine safety

A few new Salmonella Typhi vaccines use live attenuated strains of the bacteria, but such methods can mean the salmonella is shed into the environment through excrement. Researchers at Arizona State University's Biodesign Institute have been researching ways to detect S. Typhi--the cause of typhoid fever--in feces after use of the vaccine.

Genetic tweaking could create chlamydia vaccine

There is currently no chlamydia vaccine, but an Indiana University researcher has been given $2.3 million to try to create one.

Adult vaccinations stay low in U.S.

It's understandable that kids don't like getting shots, but you would think that the grown-ups know what's good for them. Not so, perhaps--a recent report from the national Centers for...

FDA experts back Pfizer's Prevnar 13 for older adults

In a 14-1 vote, a panel of FDA experts say Pfizer's ($PFE) Prevnar 13 protected adults over 50 from pneumococcal infections, paving the way for a likely approval in January. Earlier this week agency

Shingles vaccination levels fall short of expectations

Five years ago, Merck gained FDA approval for its shingles prevention vaccine Zostavax. The agency recently expanded that approval to adults 50 years and older. Yet vaccination rates remain low due

Adult vaccines cut down on healthcare costs

Keeping up-to-date with adult vaccines can cut down on future healthcare costs, according to a report published by the AP. But there are several factors standing in the way of regular immunizations.